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Diaphragm weakness affects up to 60% of ventilated patients leading to muscle atrophy, reduction 
of muscle fiber force via muscle fiber injuries and prolonged weaning from mechanical ventilation. 
Electromagnetic stimulation of the phrenic nerve can induce contractions of the diaphragm 
and potentially prevent and treat loss of muscular function. Recommended safety distance of 
electromagnetic coils is 1 m. The aim of this study was to investigate the magnetic flux density in a 
typical intensive care unit (ICU) setting. Simulation of magnetic flux density generated by a butterfly 
coil was performed in a Berlin ICU training center with testing of potential disturbance and heating 
of medical equipment. Approximate safety distances to surrounding medical ICU equipment were 
additionally measured in an ICU training center in Bern. Magnetic flux density declined exponentially 
with advancing distance from the stimulation coil. Above a coil distance of 300 mm with stimulation of 
100% power the signal could not be distinguished from the surrounding magnetic background noise. 
Electromagnetic stimulation of the phrenic nerve for diaphragm contraction in an intensive care unit 
setting seems to be safe and feasible from a technical point of view with a distance above 300 mm to 
ICU equipment from the stimulation coil.
Muscle atrophy, reduction of muscle fiber force and muscle fiber injuries are characteristics of ventilator-induced 
diaphragm  dysfunction1–3. Mechanical ventilation applying positive pressure was shown to induce diaphragm 
muscle atrophy, loss of diaphragm strength, and adverse patient outcome in critically ill  patients4–8. Diaphragm 
weakness affects approximately 60% of ventilated patients at the time of first spontaneous breathing  trial9–11 
and is twice as often as limb muscle  weakness10. Disuse atrophy of the diaphragm can be observed within 12 h 
of mechanical ventilation and is the main culprit leading to ventilator-induced diaphragm  dysfunction1,3,6,7. 
With up to 40% of critically ill patients on a medical intensive care unit (ICU) requiring mechanical ventilation, 
20–25% may develop weaning  problems8,12,13. Preserving diaphragm strength might be key to better weaning 
and improved patients outcome.
Electromagnetic stimulation of the phrenic nerve for diaphragm contraction and thus generating negative 
intrathoracic pressure might be an option for more physiological ventilation of critically ill patients requiring 
mechanical  ventilation4,14,15. So far stimulation of the phrenic nerve was achieved using invasive techniques for 
electrical  stimulation2,16,17.
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Safety instructions recommend a minimum distance to magnetically-sensitive objects of 1 m and do 
not permit direct use on the heart. Further the use in patients with life-sustaining or supporting implants is 
 contraindicated18. For that reason, we tested whether the use of electromagnetic stimulation is possible in an 
ICU setting to gain knowledge on patient’s safety when using electromagnetic stimulation of the phrenic nerve 
in patients with mechanical ventilation.
Methods
We simulated a typical intensive care unit (ICU) setting to (1) measure distances between the patient and exter-
nal medical equipment in a typical intensive care unit surrounding and (2) measure the magnetic flux density 
generated by the magnetic coils used for stimulation of the phrenic nerve. Since no patients were included in 
the study, there was no IRB approval necessary.
This simulation study was conducted twice at the Berliner Simulations- und Trainingszentrum at Charité—
Universitätsmedizin Berlin in December 2019 and May 2020. For generalizability distance measurements were 
conducted at a second academic center (Inselspital Bern) in a typical ICU setting.
A typical ICU patient room was simulated and equipped with a Progressa bed (HILLROM BV, Amsterdam, 
The Netherlands), a Primus mechanical ventilator (Drägerwerk AG & Co. KGaA, Lübeck, Germany), an Injec-
tomat MC Agilia (Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany) and the PowerM Research 100 
Stimulator (MAG & More GmbH, München, Germany) using a butterfly coil for stimulation (PMD70-pCool). 
For measuring of the magnetic flux density, a F3A Magnetic Transducer with fully integrated 1-/2-/3-axis hall 
probe (SENIS, Baar, Switzerland) was used. A Philips IntelliVue X2 monitor (Philips GmbH, Health Systems, 
Hamburg Germany) was used to investigate disturbances in electrocardiogram during stimulation. A resuscita-
tion manikin was used to simulate the patient’s position in bed.
Stimulation of the phrenic nerve was performed at the muscle-free triangle at the neck just above the medial 
clavicula. To generate the highest possible magnetic flux density, a single biphasic stimulus at maximum intensity 
(100%) was used. Furthermore, a stimulation intensity of 40% was applied, as effectively used in earlier  studies4. 
Magnetic flux density was measured at 0 mm, 20 mm, 30 mm, 70 mm, 300 mm and 400 mm vertical to the 
center of the coil. Furthermore, one measurement horizontal to the coil was done. Reliability between different 
measurements was assessed in a laboratory at the Switzerland Innovation Park Biel/Bienne.
In May 2020, we first measured the electromagnetic noise of the environment with all equipment turned 
off. Secondly, we measured the magnetic fields generated by ICU equipment only. Afterwards we measured the 
magnetic fields generated by the coil only. Lastly, we measured the magnetic fields with both, the coil and all 
ICU equipment switched on, to evaluate the combined fact.
Finally, we tested possible heating of metal surroundings and disturbances in electrocardiogram-monitoring 
(as e.g., known from the use of surgical bipolar tweezers). To evaluate heating of metal surroundings the stimula-
tion coil was directly pointed at the bed gallow and temperature was measured with a FLIR SPOT TG165 infrared 
thermometer (FLIR Systems, Inc.). To trigger disturbances in electrocardiogram-monitoring a test person had 
to hold the electrocardiogram electrodes to enable electric conductivity. Then stimulation was applied.
Results
Distances. In our simulation the distance from the stimulation coil to the ventilator was 1.2 m. Limiting 
factor for maximum distance was the length of the breathing hose. The distance from the stimulation coil to 
the perfusor was 1 m. Further the distance from the stimulation coil to the touch panel of the bed was 0.7 m. 
Distances assessed in Bern were similar, i.e. approximately 0.8 m to the ventilator, 1 m to perfusors and to the 
vital signs monitor.
Noise. The surrounding and intrinsic magnetic noise is presented in Additional File 1, Fig. S1. Analyzing 
the frequency spectrum, a dominant frequency at 16,019 Hz can be observed at 250 mm above the coil. It is 
not found at 1 m above the coil (see Additional File 1, Fig. S2). With only ICU equipment switched on, the 
only signal detectable is at 1 m above the coil. For all other distances, the signal is below noise level (< 1 mT, see 
Additional File 1, Fig. S3a). With only the stimulator switched on and all other equipment switched off, a typical 
magnetic field response can be measured up to a distances of 200 mm above the coil. In greater distances the sig-
nal cannot be distinguished from background noise. For distances up to 100 mm above the coil, a dominant fre-
quency at around 6 kHz is observed, corresponding to a pulse length of 0.166 ms (see Additional File 1, Fig. S3b).
At both, ICU equipment and stimulator switched on, typical magnetic field responses can be measured 
up to 200 mm above the coil. Notably peaks at around 3 mT were detectable in greater distances (300 mm to 
1000 mm). The frequency spectrum corresponds with the frequency spectrum when ICU devices are switched 
off (see Additional File 1, Fig. S3c).
Magnetic flux density. There was a high reliability between measurements of the magnetic flux density 
(see Additional File 1, Fig. S4). At 100% power of the device the magnetic flux density at the center of the coil 
was 1000 mT (Table 1). With rising distance to the coil, the magnetic flux density declined exponentially. At a 
distance of 300 mm the magnetic flux density was 30 mT in the ICU setting and lower (7 mT) under labora-
tory conditions. At 300 mm and 400 mm, however, the signal cannot be distinguished from the surrounding 
and intrinsic magnetic noise (Fig. 1). Results and exponential decline were similar at 40% intensity and 100% 
intensity with single, biphasic impulse (Fig. 2). The magnetic flux density showed similar decline with rising 
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Table 1.  Comparison of magnetic flux density in a laboratory and ICU setting at different distances to the 
stimulation coil. B (T) magnetic flux density in Tesla.
Distance (mm) Stimulus
Magnetic flux density B (T)
laboratory setting ICU setting
40% Power 100% Power 100% Power
0 Single n.a. n.a. 1
2 Single 0.111 0.269 n.a.
10 Single 0.084 0.202 n.a.
20 Single 0.058 0.138 0.3
30 Single 0.040 0.096 0.2
70 Single 0.011 0.028 0.1
150 Single 0.003 0.008 0.03
300 Single 0.003 0.007 0.05
400 Single 0.002 0.006 0.03
1000 Single 0.004 0.003 n.a
Figure 1.  Magnetic flux density at different distances vertical to the coil. Measurements at different distances 
to the stimulation coil were done. At 300 mm and 400 mm a lot of artefacts occurred and no clear signal was 
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Heating and disturbances. With 85% intensity, a frequency of 20 Hz and 2 to 3 sequences with a length 
of 5 to 10 s the bed gallow heated to 70 °C at direct contact between the coil and the gallow. Simultaneously, the 
stimulation coil quickly heated up to the maximum temperature of 40 °C leading to a safety stop. At a distance 
of 5 cm to the gallow slight warming was detectable after 5–10 s of stimulation.
The electrocardiogram electrodes did not heat up. The electrocardiogram signal at the monitor showed 
artefacts during stimulation as known from surgical bipolar tweezers.
All other surrounding medical equipment as described above did not show any malfunction as well as direct 
stimulation of the perfusors.
Figure 2.  Magnetic flux density at different test points. Measurement of magnetic flux density at different test 
points in laboratory. Magnetic flux density showed exponential decline with distance from the coil surface. 
Measurements were done at 100% and 40% power. Points are connected with lines for visual guidance. B 
magnetic flux density (Tesla).
Figure 3.  Magnetic flux density in ICU setting at different test points. Measurement of the magnetic flux 
density was done at different test points in the ICU with only ICU equipment switched on, only stimulator 
switched on and ICU and stimulator switch on at the same time. Points are connected with lines for visual 
guidance. B magnetic flux density (Tesla).
5
Vol.:(0123456789)
Scientific Reports |        (2021) 11:16317  | https://doi.org/10.1038/s41598-021-95489-3
www.nature.com/scientificreports/
Discussion
In this simulation study we measured magnetic flux densities at different distances to a stimulation coil to gain 
knowledge on possible interferences with electronic equipment in an ICU setting. Magnetic flux density showed 
an exponentially decline with distance to the coil with no detectable signal distinguishable from surrounding 
noise above 300 mm.
We did not find any information on maximum magnetic flux densities safe to use near ventilators apart from 
general warnings that portable and mobile radiofrequency communications equipment can affect ventilators and 
that special precautions regarding electromagnetic compatibility are  mandatory19,20. Regulations of magnetic 
stimulation devices embrace to not use the stimulation coils closer than 1 m to any sensitive  electronics21,22. 
Of note these regulations are designed for transcranial magnetic stimulation, the most common clinical use. 
However, in a non-ICU setting of repetitive transcranial magnetic stimulation in 30 pregnant women with 
depression a safety distance below 1 m was safely  used23. Furthermore, repetitive transcranial stimulation was 
well tolerated and the subsequent follow-up study on the children of these women did not show poorer cogni-
tive or motor  development24.
In an ICU setting, however, the major concern is interference of the electromagnetic field with life-sustaining 
equipment. Only three studies were investigating magnetic stimulation in critically ill patients, two in patients 
with refractory status epilepticus, one to assess diaphragm  weakness10,25–27. Liu et al. applied 70% output when 
using repetitive transcranial magnetic stimulation for refractory focal status epilepticus in intubated and sedated 
patients. To avoid any disruptions of sensitive medical equipment they repeatedly discharged their butterfly 
coil at 100% output in midair without any interference. In that study, the following equipment was not harmed 
during stimulation: clinical computer console, vital signs monitor, ventilator, medication pump, feeding pump, 
bed, pneumatic boot machine, and  electroencephalogram26. Thordstein et al. applied 60 min of stimulation with 
0.5 Hz at a 68-year old patient with refractory partial status epilepticus using a butterfly coil as  well25. In the third 
study using bilateral magnetic phrenic nerve stimulation to assess diaphragmatic dysfunction in 76 mechanically 
ventilated patients two figure-of-eight coils were used. A maximum stimulator output (100%) was  applied10. In 
all three studies no adverse events related to the stimulation were reported. No interference with ICU equipment 
and monitoring was reported in all three ICU studies, however, there was no description of distances of the ICU 
equipment and the stimulation coil. Our study is the first to investigate the distances between the stimulation 
coil and the surrounding equipment as well as the magnetic flux decline.
As there are only few studies using electromagnetic stimulation in ICU, patients’ safety remains an issue. 
Current Guidelines of the International Commission on Non-Ionizing Radiation Protection describe any magnetic 
flux density up to 0.1 mT as not harmful for human  beings28. Our results at 100% power show these 0.1 mT are 
reached at a distance of 1 m to the coil. To further address safety measures dosimetry can be used to determine 
the induced electrical field. However, the current European Respiratory Society statement on Respiratory Muscle 
Testing at Rest and during Exercise declares that it is possible to assess diaphragmatic contractility in critically 
ill, intubated patients by magnetic stimulation of the phrenic  nerve29. In a study using electromagnetic stimula-
tion of the phrenic nerve in 10 healthy probands no safety issues were  reported4. 6 volunteers reported dental 
paresthesia during stimulation which can be confirmed by our own observations. They used 20%, 30% and 
40% output of the stimulator which was well tolerated. Using more output led to strong muscle activation and 
discomfort in probands. Adler et al. also used stimulation of the phrenic nerve for diaphragm contraction in 7 
healthy  probands30. They also did not report any safety issues. Tolerance by test persons was good though with 
increasing intensity discomfort was also increasing.
The generalizability of our study may be limited because we only measured distances in two ICU settings, 
however, both were quite similar. Secondly, we are only able to make statements of missing disturbances for the 
equipment mentioned above. Since there was no signal discriminable from background noise above 300 mm, a 
safety distance above that range should be safe independent of the ICU equipment manufacturer.
In conclusion, electromagnetic stimulation seems possible in an ICU environment with adequate safety 
distance. At distances above 300 mm only background noise could be measured.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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